Multi-antigen pan-sarbecovirus DNA vaccines generate protective T cell immune responses

Jeroen van Bergen; Marcel Camps; Iris N. Pardieck; Dominique Veerkamp; Wing Yan Leung; Anouk A. Leijs; Sebenzile K. Myeni; Marjolein Kikkert; Ramon Arens; Gerben C. Zondag; Ferry Ossendorp

doi:10.1172/jci.insight.172488

Multi-antigen pan-sarbecovirus DNA vaccines generate protective T cell immune responses

Jeroen van Bergen,¹ Marcel Camps,² Iris N. Pardieck,² Dominique Veerkamp,² Wing Yan Leung,³ Anouk A. Leijs,⁴ Sebenzile K. Myeni,⁴ Marjolein Kikkert,⁴ Ramon Arens,² Gerben C. Zondag,³ and Ferry Ossendorp²

Published September 14, 2023 - More info

View PDF

Abstract

SARS-CoV-2 is the third zoonotic coronavirus to cause a major outbreak in humans in recent years, and many more SARS-like coronaviruses with pandemic potential are circulating in several animal species. Vaccines inducing T cell immunity against broadly conserved viral antigens may protect against hospitalisation and death caused by outbreaks such viruses. We report the design and pre-clinical testing of two T-cell-based pan-sarbecovirus vaccines, based on conserved regions within viral proteins of sarbecovirus isolates of human and other carrier animals, like bats and pangolins. One vaccine (CoVAX_ORF1ab) encoded antigens derived from non-structural proteins, the other (CoVAX_MNS) antigens from structural proteins. Both multi-antigen DNA vaccines contained a large set of antigens shared across sarbecoviruses and were rich in predicted and experimentally validated human T cell epitopes. In mice, the multi-antigen vaccines generated both CD8 and CD4 T cell responses to shared epitopes. Upon encounter of full-length spike antigen, CoVAX_MNS-induced CD4 T cells were responsible for accelerated CD8 T cell and IgG antibody responses specific to the incoming spike, irrespective of its sarbecovirus origin. Finally, both vaccines elicited partial protection against a lethal SARS-CoV-2 challenge in human-ACE2-transgenic mice. These results support clinical testing of this universal sarbecovirus vaccine for pandemic preparedness.

Multi-antigen pan-sarbecovirus DNA vaccines generate protective T cell immune responses

Jeroen van Bergen,¹ Marcel Camps,² Iris N. Pardieck,² Dominique Veerkamp,² Wing Yan Leung,³ Anouk A. Leijs,⁴ Sebenzile K. Myeni,⁴ Marjolein Kikkert,⁴ Ramon Arens,² Gerben C. Zondag,³ and Ferry Ossendorp²

Article tools

Metrics

Go to

Multi-antigen pan-sarbecovirus DNA vaccines generate protective T cell immune responses

Jeroen van Bergen,1 Marcel Camps,2 Iris N. Pardieck,2 Dominique Veerkamp,2 Wing Yan Leung,3 Anouk A. Leijs,4 Sebenzile K. Myeni,4 Marjolein Kikkert,4 Ramon Arens,2 Gerben C. Zondag,3 and Ferry Ossendorp2

Article tools

Metrics

Go to

Sign up for email alerts

Jeroen van Bergen,¹ Marcel Camps,² Iris N. Pardieck,² Dominique Veerkamp,² Wing Yan Leung,³ Anouk A. Leijs,⁴ Sebenzile K. Myeni,⁴ Marjolein Kikkert,⁴ Ramon Arens,² Gerben C. Zondag,³ and Ferry Ossendorp²